TAL Effector Assembly Platform for Precise Genome Engineering

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current genome engineering tools, such as ZFNs and meganucleases, face challenges with off-target cleavage, limited specificity, and difficulty in predicting and designing binders, which hinders their flexibility and reliability for genetic manipulation.

Innovation Solution

The development of compositions and methods for designing and assembling nucleic acid molecules, including TAL effector molecules, to efficiently bind to specific DNA sequences, using linear nucleic acid molecules with covalently bound topoisomerase and recombination sites, allowing for precise genetic manipulation and modification.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If ZFNs and meganucleases are used for genome engineering, then genetic manipulation capability is achieved, but off-target cleavage and limited specificity occur

Engineering Contradiction:
Improvespecificity of DNA bindingVSAvoidoff-target cleavage
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The TAL effector is divided into multiple repeat units, each recognizing a specific DNA base pair. This segmentation allows precise customization of DNA binding specificity by arranging different repeat types in a defined sequence, thereby achieving high target specificity while minimizing off-target effects

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Each TAL repeat unit has specific amino acid residues at positions 12 and 13 (RVD) that determine base recognition specificity. By locally optimizing these residues in each repeat, the system achieves high specificity for the intended target sequence while maintaining overall protein stability and function

Inventive Principle:
Principle #3Local quality

2Adaptability or versatility

If traditional genome engineering tools are used, then DNA binding capability is achieved, but difficulty in predicting and designing binders occurs

Engineering Contradiction:
Improveease of designing new bindersVSAvoidcomplexity of binder design process
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The invention establishes a direct code between amino acid sequences in TAL repeats and the DNA bases they recognize. By changing the RVD parameters in each repeat, researchers can predictably design binders for any desired DNA sequence, greatly simplifying the design process while maintaining adaptability to different target sequences

Inventive Principle:
Principle #35Parameter changes

3Manufacturing precision

If customized TAL effector molecules are assembled, then precision of genetic engineering is improved, but assembly complexity increases

Engineering Contradiction:
Improveprecision of genetic manipulationVSAvoidassembly process complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The TAL effector coding sequence is divided into multiple repeat-coding modules that can be independently synthesized and assembled. This modular segmentation enables precise assembly of customized effectors targeting specific DNA sequences while managing the complexity through standardized module interfaces

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The repeat units are pre-designed and synthesized with correct sequences before assembly. This preliminary preparation of standardized modules simplifies the final assembly process and ensures precision in the resulting customized TAL effector molecule

Inventive Principle:
Principle #10Preliminary action

Data Source

PatentUS10745695B2TAL-effector assembly platform, customized services, kits and assays
Publication Date: 2020.08.18 LIFE TECHNOLOGIES CORP
  • US10745695B2 patent drawing
  • US10745695B2 patent drawing
  • US10745695B2 patent drawing

AI summary

The invention generally relates to compositions and methods for designing and producing functional DNA binding effector molecules and associated customized services, tool kits and functional assays. In some aspects, the invention provides methods and tools for efficient assembly of customized TAL effector molecules. Furthermore, the invention relates to uses of TAL effector molecules and functional evaluation of such TAL by, for example, customized assays.